577 related articles for article (PubMed ID: 17970889)
1. Systemic ciclosporin and tacrolimus in dermatology.
Madan V; Griffiths CE
Dermatol Ther; 2007; 20(4):239-50. PubMed ID: 17970889
[TBL] [Abstract][Full Text] [Related]
2. Update on the use of ciclosporin in immune-mediated dermatoses.
Griffiths CE; Katsambas A; Dijkmans BA; Finlay AY; Ho VC; Johnston A; Luger TA; Mrowietz U; Thestrup-Pedersen K
Br J Dermatol; 2006 Jul; 155 Suppl 2():1-16. PubMed ID: 16774579
[TBL] [Abstract][Full Text] [Related]
3. Potential new indications of topical calcineurin inhibitors.
Luger T; Paul C
Dermatology; 2007; 215 Suppl 1():45-54. PubMed ID: 18174692
[TBL] [Abstract][Full Text] [Related]
4. [New immune suppressants: topical immunomodulatory agents].
Senatorski G; Sułowicz W; Paczek L
Przegl Lek; 2002; 59(11):907-11. PubMed ID: 12715720
[TBL] [Abstract][Full Text] [Related]
5. [The use of tacrolimus in dermatology].
Slodownik D; Ingber A
Harefuah; 2003 Nov; 142(11):770-4, 805. PubMed ID: 14631910
[TBL] [Abstract][Full Text] [Related]
6. Topical calcineurin inhibitors for the treatment of vulvar dermatoses.
Goldstein AT; Thaçi D; Luger T
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):22-9. PubMed ID: 19631446
[TBL] [Abstract][Full Text] [Related]
7. The macrolide immunosuppressants in dermatology: mechanisms of action.
Marsland AM; Griffiths CE
Eur J Dermatol; 2002; 12(6):618-22. PubMed ID: 12459545
[TBL] [Abstract][Full Text] [Related]
8. Innovative use of topical calcineurin inhibitors.
Lin AN
Dermatol Clin; 2010 Jul; 28(3):535-45. PubMed ID: 20510763
[TBL] [Abstract][Full Text] [Related]
9. The use of cyclosporine in dermatology.
Dehesa L; Abuchar A; Nuno-Gonzalez A; Vitiello M; Kerdel FA
J Drugs Dermatol; 2012 Aug; 11(8):979-87. PubMed ID: 22859244
[TBL] [Abstract][Full Text] [Related]
10. The use of topical tacrolimus and pimecrolimus to treat psoriasis: a review.
Scheinfeld N
Dermatol Online J; 2004 Jul; 10(1):3. PubMed ID: 15347485
[TBL] [Abstract][Full Text] [Related]
11. Pimecrolimus in dermatology: atopic dermatitis and beyond.
Gisondi P; Ellis CN; Girolomoni G
Int J Clin Pract; 2005 Aug; 59(8):969-74. PubMed ID: 16033622
[TBL] [Abstract][Full Text] [Related]
12. Safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.
Munzenberger PJ; Montejo JM
Pharmacotherapy; 2007 Jul; 27(7):1020-8. PubMed ID: 17594208
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive agents in dermatology.
Ho VC; Zloty DM
Dermatol Clin; 1993 Jan; 11(1):73-85. PubMed ID: 8435920
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine in Dermatology.
Kutlubay Z; Erdogan BÇ; Engin B; Serdaroglu S
Skinmed; 2016; 14(2):105-9. PubMed ID: 27319953
[TBL] [Abstract][Full Text] [Related]
15. Potential future dermatological indications for tacrolimus ointment.
Ruzicka T; Assmann T; Lebwohl M
Eur J Dermatol; 2003; 13(4):331-42. PubMed ID: 12948911
[TBL] [Abstract][Full Text] [Related]
16. The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force.
Berger TG; Duvic M; Van Voorhees AS; VanBeek MJ; Frieden IJ;
J Am Acad Dermatol; 2006 May; 54(5):818-23. PubMed ID: 16635663
[No Abstract] [Full Text] [Related]
17. A review and update of the clinical uses of cyclosporine in dermatology.
Groisser DS; Griffiths CE; Ellis CN; Voorhees JJ
Dermatol Clin; 1991 Oct; 9(4):805-17. PubMed ID: 1934654
[TBL] [Abstract][Full Text] [Related]
18. [Tacrolimus in diseases other than atopic dermatitis].
Alomar A; Corella F; García-Navarro X
Actas Dermosifiliogr; 2008 Feb; 99 Suppl 2():26-35. PubMed ID: 18346427
[TBL] [Abstract][Full Text] [Related]
19. Calcineurin inhibitors in oral medicine.
Al Johani KA; Hegarty AM; Porter SR; Fedele S
J Am Acad Dermatol; 2009 Nov; 61(5):829-40. PubMed ID: 19836643
[TBL] [Abstract][Full Text] [Related]
20. Topical pimecrolimus in the treatment of seborrheic dermatitis.
Brownell I; Quan LT; Hsu S
Dermatol Online J; 2003 Aug; 9(3):13. PubMed ID: 12952760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
